Charcot-Leyden crystals in the trephine biopsy of a patient with a FIP1L1-PDGFRA - positive myeloproliferative disorder.
Lyall
Hamish
H
Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK. hdlyall@doctors.org.uk
O'Connor
Simon
S
Clark
David
D
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D001706:Biopsy; D001853:Bone Marrow / Q000737:chemistry*; D001856:Bone Marrow Examination; D003460:Crystallization; D004802:Eosinophilia; D006023:Glycoproteins / Q000032:analysis*; D006801:Humans; D000068877:Imatinib Mesylate; D008245:Lysophospholipase / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000188:drug therapy / Q000378:metabolism*; D015514:Oncogene Proteins, Fusion / Q000378:metabolism*; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000378:metabolism*; D039221:mRNA Cleavage and Polyadenylation Factors / Q000378:metabolism*
D000970:Antineoplastic Agents; D001549:Benzamides; D006023:Glycoproteins; D015514:Oncogene Proteins, Fusion; D010879:Piperazines; D011743:Pyrimidines; D039221:mRNA Cleavage and Polyadenylation Factors; D000068877:Imatinib Mesylate; C479819:FIP1L1-PDGFRA fusion protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha; D008245:Lysophospholipase; C011711:lysolecithin acylhydrolase